Collaboration Station

Where CMI, Compas, Singularity, InfoCures, & MEDtrak Come Together!

Pharmalot Takes a Deep Dive into our DTC Study May 7, 2013

Filed under: Corporate — CMI/Compas @ 6:27 pm

Pharmalot reported on the CMI/Compas DTC advertising study, highlighting the study found that 52% of physicians agree DTC advertising removes the stigma associated with certain diseases. Pharmalot dissects our study, conducted using our proprietary ByDoctor PULSE software, and lists more of the surprising findings in this article.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s